Group VI Phospholipases A2

"Group VI Phospholipases A2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A calcium-independent phospholipase A2 group that may play a role in membrane phospholipid remodeling and homeostasis by controling the levels of PHOSPHATIDYLCHOLINE in mammalian cell membranes.

Descriptor ID

D054522

MeSH Number(s)

D08.811.277.352.100.680.750.937.300.249

Concept/Terms

Group VI Phospholipases A2

Below are MeSH descriptors whose meaning is more general than "Group VI Phospholipases A2".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Esterases [D08.811.277.352]
Carboxylic Ester Hydrolases [D08.811.277.352.100]
Phospholipases [D08.811.277.352.100.680]
Phospholipases A [D08.811.277.352.100.680.750]
Phospholipases A2 [D08.811.277.352.100.680.750.937]
Phospholipases A2, Calcium-Independent [D08.811.277.352.100.680.750.937.300]
Group VI Phospholipases A2 [D08.811.277.352.100.680.750.937.300.249]

Below are MeSH descriptors whose meaning is related to "Group VI Phospholipases A2".

Below are MeSH descriptors whose meaning is more specific than "Group VI Phospholipases A2".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Group VI Phospholipases A2" by people in Harvard Catalyst Profiles by year, and whether "Group VI Phospholipases A2" was a major or minor topic of these publication.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	0	1	1
2010	1	0	1
2014	1	0	1
2015	2	0	2
2016	2	0	2
2017	0	1	1
2018	0	1	1
2019	1	0	1

Below are the most recent publications written about "Group VI Phospholipases A2" by people in Profiles.

Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2ß/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 ß-cells. Int J Biol Sci. 2019; 15(7):1533-1545.

View in: PubMed
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways. Nat Commun. 2018 11 14; 9(1):4774.

View in: PubMed
Rare germline variants in known melanoma susceptibility genes in familial melanoma. Hum Mol Genet. 2017 12 15; 26(24):4886-4895.

View in: PubMed
PLA2G6 mutations and Parkinsonism: Long-term follow-up of clinical features and neuropathology. Mov Disord. 2016 12; 31(12):1927-1929.

View in: PubMed
Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families. BMC Res Notes. 2016 Jun 07; 9:295.

View in: PubMed
Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain. 2015 Jul; 138(Pt 7):1801-16.

View in: PubMed
A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism. Parkinsonism Relat Disord. 2015 Mar; 21(3):337-9.

View in: PubMed
IPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis. J Int Acad Periodontol. 2014 Oct; 16(4):121-6.

View in: PubMed
Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4. Arterioscler Thromb Vasc Biol. 2014 Apr; 34(4):768-78.

View in: PubMed
Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neurosci Lett. 2012 Aug 08; 523(1):35-8.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Twin Res Hum Genet
Parkinsonism Relat Disord
Mov Disord
J Int Acad Periodontol
J Immunol
Int J Biol Sci
Brain
BMC Res Notes
Arterioscler Thromb Vasc Biol
Carcinogenesis